Mylan Specialty, L.P.

Lawsuit Filings

Class Action Claims Mylan, Pfizer Manipulated EpiPen Expiration Dates to Increase Sales [UPDATE]

March 6, 2020 A proposed class action alleges the makers of EpiPen have intentionally manipulated expiration dates in order to force consumers to refill their prescriptions more often.

Mylan Sued in Alabama Over Purportedly Illegal EpiPen Pricing Scheme

July 24, 2017 Mylan Pharmaceuticals, Inc. and Mylan Specialty, L.P. are facing another proposed class action – this time filed in Alabama – alleging that they charged consumers unlawfully high prices for their EpiPen products.